Skip to main content

IL28B genotypes strongly influence early viral kinetics in HIV/HCV-coinfected patients treated with peginterferon-α/ribavirin - implications using directly acting antivirals

Publication ,  Conference
Rallon, NI; Naggie, S; Restrepo, C; McHutchison, J; Soriano, V; Benito, JM
Published in: ANTIVIRAL THERAPY
2011

Duke Scholars

Published In

ANTIVIRAL THERAPY

ISSN

1359-6535

Publication Date

2011

Volume

16

Start / End Page

A91 / A91

Related Subject Headings

  • Virology
  • 3207 Medical microbiology
  • 3202 Clinical sciences
  • 3107 Microbiology
  • 1108 Medical Microbiology
  • 1103 Clinical Sciences
  • 0605 Microbiology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Rallon, N. I., Naggie, S., Restrepo, C., McHutchison, J., Soriano, V., & Benito, J. M. (2011). IL28B genotypes strongly influence early viral kinetics in HIV/HCV-coinfected patients treated with peginterferon-α/ribavirin - implications using directly acting antivirals. In ANTIVIRAL THERAPY (Vol. 16, pp. A91–A91).
Rallon, N. I., S. Naggie, C. Restrepo, J. McHutchison, V. Soriano, and J. M. Benito. “IL28B genotypes strongly influence early viral kinetics in HIV/HCV-coinfected patients treated with peginterferon-α/ribavirin - implications using directly acting antivirals.” In ANTIVIRAL THERAPY, 16:A91–A91, 2011.

Published In

ANTIVIRAL THERAPY

ISSN

1359-6535

Publication Date

2011

Volume

16

Start / End Page

A91 / A91

Related Subject Headings

  • Virology
  • 3207 Medical microbiology
  • 3202 Clinical sciences
  • 3107 Microbiology
  • 1108 Medical Microbiology
  • 1103 Clinical Sciences
  • 0605 Microbiology